Navigation Links
PwC's Health Research Institute Finds Shortage of Health IT Workers Could Slow Industry Progress

NEW YORK, March 12, 2013 /PRNewswire/ -- A significant and growing shortage of health information technology (HIT) workers appears greater than previously estimated, according to a new analysis by PwC's Health Research Institute (HRI). The report, entitled Solving the talent equation for health IT, finds that the healthcare industry is vying for a limited number of IT professionals – and many companies are scrambling to fill the talent void by recruiting technology specialists from other industries.


"The challenge for healthcare is not just a shortage of people with technical skills. It's also a shortage of people with the skills to marry technological savvy with business strategy as healthcare becomes more connected, coordinated and accountable," said Daniel Garrett , principal and PwC's Health Information Technology practice leader. "Despite billions of dollars spent investing in HIT, the lack of qualified professionals could slow progress toward quality and efficiency. The benefits of HIT will not be realized until organizations can ensure information is unlocked and integrated in a way to best inform critical business and clinical decision-making."

Top healthcare executives are concerned with the industry's ability to absorb change and integrate HIT into daily activity. According to the report, nearly 80 percent of global healthcare CEOs surveyed expect to increase technology investments in 2013, yet over half (51 percent) fear their staff cannot keep up with the pace of technological change. Seventy-seven percent say they are revisiting their hiring and promotion strategies to address gaping holes in health IT.

According to HRI, competition for talented HIT professionals has intensified as the industry works to meet new regulatory requirements and business goals. Organizations are discovering they must work with — rather than independently of — industry counterparts to achieve common goals for healthcare quality including patient drug adherence in a new outcomes-based environment that pays for value over volume. The ongoing challenge in HIT is finding people who understand the movement to an integrated health system, as well as the needs of providers, insurers and drug and device makers.

Under pressure to meet requirements for electronic health records (EHRs) and avoid penalties, hospitals, physicians and other caregivers have the greatest need for IT specialists in the health sector. Three-quarters (75 percent) of providers, such as hospitals and physician groups, are hiring new employees to support their IT priorities. Providers believe clinical informaticists – specialists who transform data into information used to improve care delivery – will have the most important skills for achieving their IT priorities.

HRI found that more than half (54 percent) of insurers surveyed have acquired another organization in the past 12 months. This industry consolidation has created the need to integrate systems and data from newly-acquired companies. Not surprisingly, insurers ranked systems and data integration skills as most important to meeting HIT priorities. Seventy percent of insurers said it will be very important for new hires to have informatics and data analytics skills over the next three years.

IT trends in the biopharmaceutical industry reinforce a growing need for economic outcomes research, bioinformatics and increased outsourcing to technology companies for cost savings. Demand for a new set of technology skills is emerging to support more collaborative approaches to research and to demonstrate both clinical and economic benefit. HRI's survey found that 35 percent of drug and device companies partner with clinical research organizations and 31 percent partner with academic medical centers to reduce the cost of research and development.

"The IT organization remains the critical connector to delivering real-time data and metrics to make smarter business decisions," continued PwC's Garrett. "Despite differing IT priorities, general IT staffing needs across the industry reflect a shared goal of improved health outcomes – particularly as payment shifts from a fee-for-service model that rewards value over volume."

PwC's Health Research Institute also recently published New Chemistry: Getting the biopharmaceutical talent formula right, which takes an in-depth look at the changing R&D model and what it means to workforce design. HRI's newest report, Solving the talent equation for health IT, outlines common strategies for shared HIT staffing challenges.

To download a full copy of the report, visit

About PwC's Health Research Institute (HRI)
PwC's Health Research Institute provides new intelligence, perspectives and analysis on trends affecting health-related industries. HRI helps executive decision makers navigate change through primary research and collaborative exchange. Our views are shaped by a network of professionals with executive and day-to-day experience in the health industry. HRI research is not sponsored by businesses, government, or other institutions. For more information, visit

About PwC's Health Industries Group
PwC's Health Industries Group is a leading advisor to public and private organizations across the health industries, including healthcare providers, pharmaceuticals, health and life sciences, payers, employers, academic institutions and non-health organizations with significant presence in the health market. For more information, follow PwC Health Industries at @PwCHealth or visit

About PwC US
PwC US helps organizations and individuals create the value they're looking for. We're a member of the PwC network of firms in 158 countries with more than 180,000 people. We're committed to delivering quality in assurance, tax and advisory services. Tell us what matters to you and find out more by visiting us at

Learn more about PwC by following us online: @PwC_LLPYouTube, LinkedIn, Facebook and Google +.

© 2013 PricewaterhouseCoopers LLP, a Delaware limited liability partnership. All rights reserved. PwC refers to the US member firm, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see for further details.

This content is for general information purposes only, and should not be used as a substitute for consultation with professional advisors.

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. California Healthcare Institute Appoints Vice President-State Government Affairs
2. BioElectronics Product Cited for "Most Innovative New OTC Product" From Leading UK-based Healthcare Marketing Publication
3. New Research Shows Probiotics are good for more than just Digestive and Skin Care Health, Probiotic Action Explains the News
4. Abacus International Expands Annual Partnership With HealthEconomics.Com
5. Metanomics Health and the Drug Safety Executive Councilâ„¢ (DSEC) expand the scope of MetaMap®Tox
6. Wipro Launches Wipro AssureHealth Platform on Microsoft Technologies
7. Creative Entrepreneur is Shaping Affordable Health Care Alternatives
8. BioHealth Innovation, Inc. President & CEO Richard Bendis to Present at SXSW 2013 & 2013 BIO International Convention
9. GNS Healthcare Joins Orion Bionetworks to Develop Predictive Models for Multiple Sclerosis and Other Diseases
10. Palatin Technologies, Inc. To Present At The Cowen & Company 33rd Annual Health Care Conference
11. Burrell Behavioral Health Improves Care and Patient Security by Implementing Hyland Softwares OnBase
Post Your Comments:
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):